Aspira Women's Health Inc.
AWHL· OTC
Released Nov 10, 2022, during market hours
10-Q filed Nov 10, 2022, 41 days after period end · 0000926617-22-000058
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $2.07M | $1.67M | $1.24M | $1.29M |
| Net Income | -$7.78M | -$9.71M | -$4.29M | -$3.82M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$1.00 |
| -$0.09 |
| -$0.04 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.